Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease-2019 (COVID-19): An Updated Review
Mithun Rudrapal, Shubham J. Khairnar, Laxmikant B. Borse, et al.
Drug Research (2020) Vol. 70, Iss. 09, pp. 389-400
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
Mithun Rudrapal, Abdul Rashid Issahaku, Clement Agoni, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10437-10453
Closed Access | Times Cited: 64
Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
Mithun Rudrapal, Neelutpal Gogoi, Dipak Chetia, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 4, pp. 2432-2446
Open Access | Times Cited: 62
Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
Mithun Rudrapal, İsmail Çeli̇k, Johra Khan, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 3, pp. 101826-101826
Open Access | Times Cited: 62
Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
Mithun Rudrapal, İsmail Çeli̇k, Sampath Chinnam, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 5, pp. 3456-3465
Open Access | Times Cited: 45
Computational Investigations for Identification of Bioactive Molecules from Baccaurea ramiflora and Bergenia ciliata as Inhibitors of SARS-CoV-2 Mpro
James H. Zothantluanga, Mohnad Abdalla, Mithun Rudrapal, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 3, pp. 2459-2487
Closed Access | Times Cited: 27
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Comparative study of a mathematical epidemic model, statistical modeling, and deep learning for COVID-19 forecasting and management
Mohammad Masum, M. A. Masud, Muhaiminul Islam Adnan, et al.
Socio-Economic Planning Sciences (2022) Vol. 80, pp. 101249-101249
Open Access | Times Cited: 26
Protease inhibitors targeting the main protease and papain-like protease of coronaviruses
Clemente Capasso, Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 4, pp. 309-324
Closed Access | Times Cited: 32
Development of gold nanoparticle-based biosensors for COVID-19 diagnosis
Johra Khan, Yousef Rasmi, Kevser Kübra Kırboğa, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Increased incidence of acute primary angle closure during the COVID-19 outbreak in China: A retrospective analysis
Zhiqiao Liang, Kangyi Yang, Kun Lv, et al.
Medicine (2024) Vol. 103, Iss. 18, pp. e38030-e38030
Open Access | Times Cited: 3
A blood RNA transcriptome signature for COVID-19
Philip Kam Weng Kwan, Gail Brenda Cross, Claire M. Naftalin, et al.
BMC Medical Genomics (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Willingness to Receive a COVID-19 Vaccine and Associated Factors among Older Adults: A Cross-Sectional Survey in Shanghai, China
Linlin Wu, Xiaolan Wang, Ruiping Li, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 654-654
Open Access | Times Cited: 15
Resveratrol and Its Natural Analogues Inhibit RNA Dependant RNA Polymerase (RdRp) of Rhizopus oryzae in Mucormycosis through Computational Investigations
İsmail Çeli̇k, Mithun Rudrapal, Pradeep Kumar Yadalam, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 5, pp. 4426-4443
Closed Access | Times Cited: 12
A Review of Mathematical Models of COVID-19 Transmission
Huan Yang, Xiaolin Lin, Jianquan Li, et al.
Contemporary Mathematics (2023), pp. 75-98
Open Access | Times Cited: 7
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?
Bhargab Kalita, Anthony J. Saviola, Stephen P. Samuel, et al.
International Journal of Biological Macromolecules (2021) Vol. 192, pp. 1040-1057
Open Access | Times Cited: 14
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication
Elisa Bianconi, Anna Gidari, Maria Souma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)
Eleni Papakonstantinou, Konstantina Dragoumani, Αspasia Efthimiadou, et al.
Oncology Letters (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 13
Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities
Amir Reza Safdarian, Kaveh Momenzadeh, Farima Kahe, et al.
Clinical Case Reports (2020) Vol. 9, Iss. 1, pp. 461-464
Open Access | Times Cited: 13
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program
Ridhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
El clima organizacional de una universidad en tiempos del COVID-19
Enerieth Lozano Mejía, Carlos Tello-Castrillón
Revista CEA (2024) Vol. 10, Iss. 22, pp. e2702-e2702
Open Access | Times Cited: 1
Use of Immunoglobulin Y Antibodies: Biosensor-based Diagnostic Systems and Prophylactic and Therapeutic Drug Delivery Systems for Viral Respiratory Diseases
Yasemin Budama‐Kilinc, Ozan Baris Kurtur, Bahar Gök, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 11, pp. 973-985
Closed Access | Times Cited: 1
Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery
Mithun Rudrapal
IntechOpen eBooks (2022)
Open Access | Times Cited: 7
COVID-19 Pandemic and Compassionate Leadership: Lessons Learned from Woman in Local Governance
Andi Tenri Sompa, Abdillah Abdillah, Zahra Ahmadi
Journal of Contemporary Governance and Public Policy (2023) Vol. 4, Iss. 1, pp. 23-40
Open Access | Times Cited: 3
Recent Advances in mRNA Vaccine Development
Abebe Mengesha Aga, Musin Kelel, Mesfin Tafesse Gemeda
(2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top